MedPath

Comparison of Two Respiratory Physiotherapy Treatments in Postcovid-19 Patients.

Not Applicable
Completed
Conditions
COVID-19
Respiratory Distress Syndrome
Interventions
Device: PowerBreathe and PEP Therosold tools
Registration Number
NCT05435443
Lead Sponsor
Universidad Católica de Ávila
Brief Summary

To test the effectiveness of a respiratory physiotherapy treatment plan in patients who have passed COVID-19, comparing two randomized groups, for the performance of different respiratory musculature training protocols. To objectify the results data obtained by means of ultrasound measurements and spirometry, observing the differences obtained at the beginning and end of the study, verifying the effectiveness of the PowerBreathe® ,Therosold PEP® tools and the effectiveness of diaphragmatic, abdominal and expiratory exercises.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Patients diagnosed with Covid and suffering from functional limitations in the respiratory system.
  • Patients over 18 years of age.
  • Patients under 65 years of age.
  • Patientes with cognitive ability to perform spirometry.
  • Patients with the physical capacity to perform spirometry
Exclusion Criteria
    • Patients diagnosed with Covid and without functional limitations in the respiratory system.
  • Patients under 18 years of age.
  • Patients over 65 years of age.
  • Patients without cognitive capacity to perform spirometry.
  • Patients without physical capacity to perform spirometry.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
perform diaphragmatic breathing, series of abdominal crunches and expiratory exercises group.PowerBreathe and PEP Therosold tools-
the PowerBreathe and PEP Therosold tools groupPowerBreathe and PEP Therosold tools-
Primary Outcome Measures
NameTimeMethod
peak expiratory pressure1 month

0 miminum ,200 maximum

peak inspiratory pressure (PIM)1 month

0 miminum ,200 maximum

forced vital capacity1 month

0 miminum ,200 maximum

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Universidad Católica de Ávila

🇪🇸

Ávila, Spain

© Copyright 2025. All Rights Reserved by MedPath